Intraocular nano-microscale drug delivery systems for glaucoma treatment: design strategies and recent progress

Intraocular nano-microscale drug delivery systems for glaucoma treatment: design strategies and recent progress

Abstract Glaucoma is a leading cause of irreversible visual impairment and blindness, affecting over 76.0 million people worldwide in 2020, with a predicted increase to 111.8 million by 2040. Hypotensive eye drops remain the gold standard for glaucoma treatment, while inadequate patient adherence to...

Full description

Bibliographic Details
Main Authors: Yuening Shen, Jianguo Sun, Xinghuai Sun
Format: Article
Language:English
Published: BMC 2023-03-01
Series:Journal of Nanobiotechnology
Subjects:
Glaucoma
Nanomedicine
Drug delivery
Sustained release
Neuroprotection
Intraocular pressure
Online Access:https://doi.org/10.1186/s12951-023-01838-x

Internet

https://doi.org/10.1186/s12951-023-01838-x

Similar Items